
Sponsored Dinner Symposium
by Volpara Solutions
19 July, 1830hrs
Venue Oasia Hotel Novena, Basement 1, Courtyard 1
1. Personalising Breast Screening using Artificial Intelligence
Mary Rickard
Consultant Radiologist , Sydney Breast Clinic
Dr Mary Rickard will speak on the earliest days of artificial intelligence in breast cancer screening, discuss its merits and possibilities, and then take us towards the future discussing some of the latest technologies.
2. Finding Signal in the Noise – Applying Artificial Intelligence and Machine Learning to Health
Gabe Rijpma
Senior Director – Health and Social Services, Microsoft Asia
Gabe Rijma will talk about the some of the latest ways that healthcare technology is evolving and innovating. He will discuss the latest concepts in artificial intelligence and explore how to find “Signal in the Noise”.

Sponsored Tea Symposium
by Genomic Health
20 July, 1050hrs
Venue KKH Auditorium
TAILORx – Identifying the Right Patients for the Right Treatment
Dr Christy Russell, MD
Senior Director US Medical Affairs, Genomic Health Inc
Tumour genomic analysis has made a substantial contribution to the treatment of breast cancers. The traditional clinical parameters such as tumor size and grade are regarded as prognostic but not predictive. The Oncotype DX Breast Recurrence Score® test from Genomic Health Inc. in particular, has demonstrated its ability in guiding treatment decisions after breast surgery for hormone-receptor positive, HER2 negative breast cancer patients.
Dr Christy Russell will talk about the science of genomic testing in early breast cancers with the latest research data in the TAILORx trial.

Sponsored Lunch Symposium
by Novartis
20 July, 1310hrs
Venue KKH Auditorium
Evolving Combination Strategies in Management of HR+ve, HER2-ve Advanced Breast Cancer
Dr See Hui Ti
Medical Oncologist Consultant, Parkway Cancer Centre, Mount Elizabeth Hospital, Singapore.
The lunch symposium will focus on recent updates on HR+ HER2- advanced breast cancer treatment landscape, highlighting new data on the young breast cancer patients (MONALEESA-7 overall survival data). In addition, there will be extensive discussion on breast cancer specific mutations- the PIK3CA mutation: from its molecule conception, clinical trial results (SOLAR-1) and its role in breast cancer clinical landscape.

Sponsored Tea Symposium
by Roche
20 July, 1525hrs
Venue KKH Auditorium
Breast Conservation after Neoadjuvant Therapy – the Hong Kong Experience
Prof Ava Kwong
Chief of Division of Breast Surgery at Queen Mary Hospital, Tung Wah Hospital and The University of Hong Kong-Shenzhen Hospital
SPONSORSHIP & EXHIBITION OPPORTUNITIES
A host of sponsorship opportunities await companies/organisations. An exhibition will be organised in conjunction with the meeting and the exhibition area will be strategically located in the KKH Training Centre. Should your company be interested in participating in the Breast Day Meeting 2019 as sponsors or exhibitors, please feel free to send in your enquiries to the Secretariat at jessica.leong@eventsthreesixty.com.sg.